Aptose Biosciences logo

Aptose Biosciences APTO

report update icon

Quarterly report 2026-Q1
added 05-13-2026

Country

canadaCanada

IPO year

-

Industry

Biotechnology

Stock Exchange

NASDAQ CAPITAL

Shares

2.45 M

Market Cap[1]

$ 1.2 M

EBITDA (LTM)

$ 22 K

P/E (LTM)

-

P/S (LTM)

-

EPS (LTM)

-10.41

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
BioLineRx Ltd. BioLineRx Ltd.
BLRX
$ 2.32 2.67 % $ 5.72 B Nasdaq Capital Market israelIsrael
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
$ 60.0 0.22 % $ 11.5 B Nasdaq Global Select Market,SPB usaUSA
Bristol-Myers Squibb Company Bristol-Myers Squibb Company
BMY
$ 62.4 0.19 % $ 127 B NYSE,SPB usaUSA
Benitec Biopharma Benitec Biopharma
BNTC
$ 10.0 2.56 % $ 466 M Nasdaq Capital Market usaUSA
BioNTech SE BioNTech SE
BNTX
$ 98.3 0.02 % $ 23.8 B Nasdaq Global Select Market germanyGermany
Burford Capital Limited Burford Capital Limited
BUR
$ 3.92 0.51 % $ 859 M NYSE britainBritain
BeyondSpring BeyondSpring
BYSI
$ 0.77 2.15 % $ 31.7 M Nasdaq Capital Market usaUSA
Cabaletta Bio Cabaletta Bio
CABA
$ 1.92 0.75 % $ 193 M Nasdaq Global Select Market usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
$ 2.2 0.92 % $ 3.62 M NYSE American israelIsrael
Capricor Therapeutics Capricor Therapeutics
CAPR
$ 9.47 10.5 % $ 440 M Nasdaq Capital Market usaUSA
Catalyst Biosciences Catalyst Biosciences
CBIO
$ 14.59 1.58 % $ 1.3 B Nasdaq Capital Market usaUSA
C4 Therapeutics C4 Therapeutics
CCCC
$ 3.33 6.39 % $ 276 M Nasdaq Global Select Market usaUSA
Codexis Codexis
CDXS
$ 1.39 2.96 % $ 121 M Nasdaq Global Select Market usaUSA
Cerus Corporation Cerus Corporation
CERS
$ 2.38 0.82 % $ 454 M Nasdaq Global Market usaUSA
Certara Certara
CERT
$ 9.2 0.11 % $ 1.48 B Nasdaq Global Select Market usaUSA
Cullinan Management Cullinan Management
CGEM
$ 15.35 0.79 % $ 925 M Nasdaq Global Select Market usaUSA
Compugen Ltd. Compugen Ltd.
CGEN
$ 2.38 1.28 % $ 222 M Nasdaq Global Market,SPB israelIsrael
Coherus BioSciences Coherus BioSciences
CHRS
$ 1.21 2.54 % $ 142 M Nasdaq Global Market usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
$ 32.41 2.43 % $ 2.15 B Nasdaq Global Select Market usaUSA
CollPlant Biotechnologies Ltd. CollPlant Biotechnologies Ltd.
CLGN
$ 3.78 0.13 % $ 46.1 M Nasdaq Capital Market israelIsrael
Cellectis S.A. Cellectis S.A.
CLLS
$ 1.51 2.72 % $ 151 M Nasdaq Global Market franceFrance
Cellectar Biosciences Cellectar Biosciences
CLRB
$ 1.84 1.1 % $ 4.8 M Nasdaq Capital Market usaUSA
CNS Pharmaceuticals CNS Pharmaceuticals
CNSP
$ 5.3 8.0 % $ 2.35 M Nasdaq Capital Market usaUSA
Cocrystal Pharma Cocrystal Pharma
COCP
$ 1.15 2.68 % $ 13 M Nasdaq Capital Market usaUSA
Collegium Pharmaceutical Collegium Pharmaceutical
COLL
$ 21.82 0.44 % $ 691 M Nasdaq Global Select Market usaUSA
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
CORT
$ 115.23 0.43 % $ 12 B Nasdaq Capital Market,SPB usaUSA
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
$ 6.82 2.87 % $ 90.8 M Nasdaq Global Market usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
$ 1.21 3.42 % $ 80.9 M Nasdaq Capital Market usaUSA
Curis Curis
CRIS
$ 0.84 1.21 % $ 11.1 M Nasdaq Global Market usaUSA
CorMedix CorMedix
CRMD
$ 7.7 0.51 % $ 555 K Nasdaq Global Market usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
$ 55.32 0.02 % $ 4.97 B Nasdaq Global Market,SPB schweizSchweiz
Corvus Pharmaceuticals Corvus Pharmaceuticals
CRVS
$ 11.52 0.85 % $ 910 M Nasdaq Global Market usaUSA
Champions Oncology Champions Oncology
CSBR
$ 5.0 4.38 % $ 69.2 M Nasdaq Capital Market usaUSA
CytomX Therapeutics CytomX Therapeutics
CTMX
$ 2.72 2.23 % $ 375 M Nasdaq Global Select Market usaUSA
Citius Pharmaceuticals Citius Pharmaceuticals
CTXR
$ 0.53 0.41 % $ 5.86 M Nasdaq Capital Market usaUSA
Cue Biopharma Cue Biopharma
CUE
$ 25.87 1.41 % $ 2.45 B Nasdaq Capital Market,SPB usaUSA
CEL-SCI Corporation CEL-SCI Corporation
CVM
$ 2.06 15.73 % $ 16.5 M NYSE American,SPB usaUSA
Cytokinetics, Incorporated Cytokinetics, Incorporated
CYTK
$ 65.91 0.41 % $ 7.92 M Nasdaq Global Select Market,SPB usaUSA
Daré Bioscience Daré Bioscience
DARE
$ 0.85 4.7 % $ 9.5 M Nasdaq Capital Market usaUSA
DBV Technologies S.A. DBV Technologies S.A.
DBVT
$ 11.76 1.82 % $ 1.64 B Nasdaq Global Select Market franceFrance
DiaMedica Therapeutics DiaMedica Therapeutics
DMAC
$ 8.27 0.85 % $ 389 M Nasdaq Capital Market usaUSA
Denali Therapeutics Denali Therapeutics
DNLI
$ 20.67 0.38 % $ 3.57 B Nasdaq Global Select Market,SPB usaUSA
Precision BioSciences Precision BioSciences
DTIL
$ 6.26 1.29 % $ 80.3 M Nasdaq Global Select Market usaUSA
Dyadic International Dyadic International
DYAI
$ 0.44 0.49 % $ 15.9 M Nasdaq Capital Market usaUSA
Editas Medicine Editas Medicine
EDIT
$ 2.57 0.19 % $ 228 M Nasdaq Global Select Market,SPB usaUSA
Edesa Biotech Edesa Biotech
EDSA
$ 4.21 18.26 % $ 23.9 M Nasdaq Capital Market usaUSA
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
$ 0.5 4.73 % $ 22.8 M Nasdaq Capital Market israelIsrael
Enanta Pharmaceuticals Enanta Pharmaceuticals
ENTA
$ 13.18 4.27 % $ 281 K Nasdaq Global Select Market,SPB usaUSA
Entera Bio Ltd. Entera Bio Ltd.
ENTX
$ 2.91 8.18 % $ 134 M Nasdaq Capital Market israelIsrael
Equillium Equillium
EQ
$ 1.63 0.31 % $ 93.4 M Nasdaq Global Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.